Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARα

Journal of Lipid Research

Volumn 40, Issue 8, 1999, Pages 1426-1433

  Moya Camarena, Silvia Y ^a   Vanden Heuvel, John P ^b   Blanchard, Steven G ^c   Leesnitzer, Lisa A ^c   Belury, Martha A ^a  

^a PURDUE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Gene expression; Ligand affinity; Lipid metabolism

Indexed keywords

ACYL COENZYME A; FURAN DERIVATIVE; LIGAND; LINOLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ARTICLE; BINDING AFFINITY; GENE EXPRESSION; HEPATOMA CELL; LIGAND BINDING; LIPID METABOLISM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACYL-COA OXIDASE; ALKANE 1-MONOOXYGENASE; ANIMALS; BINDING, COMPETITIVE; CARRIER PROTEINS; CYTOCHROME P-450 ENZYME SYSTEM; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOMERISM; LIGANDS; LINOLEIC ACIDS; LIVER; MIXED FUNCTION OXYGENASES; MYELIN P2 PROTEIN; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; OXIDOREDUCTASES; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032796505     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Lavillonnière, F., J. C. Martin, P. Bougnoux, and J. L. Sébédio. 1998. Analysis of conjugated linoleic acid isomers and content in French cheeses. J. Am. Oil Chem. Soc. 75: 343-352.
2. Chin, S. F., J. M. Storkson, W. Liu, K. J. Albright, and M. W. Pariza. 1994. Conjugated linoleic acid (9,11- and 10,12-octadecanoid acid) is produced in conventional but not germ-free rats fed linoleic acid. J. Nutr. 124: 694-701.
3. Salminen, I., M. Mutanen, M. Jauhiainen, and A. Aro. 1998. Dietary trans fatty acids increase conjugated linoleic acid levels in human serum. J. Nutr. Biochem. 9: 93-98.
4. Lin, H., H. Boyslston, M. J. Chang, L. O. Leudecke, and T. D. Shultz. 1995. Survey of the conjugated linoleic acid content of dairy products. J. Dairy Sci. 78: 2358-2365.
5. Ha, Y. L., N. K. Grimm, and M. W. Pariza. 1987. Anticarcinogens from fried ground beef: heat-altered derivatives of linoleic acid. Carcinogenesis. 8: 1881-1887.
6. Ip, C., M. Singh, H. J. Thompson, and J. A. Scimeca. 1994. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res. 54: 1212-1215.
7. Belury, M.A., C. Bird, K. P. Nickel, and B. Wu. 1996. Inhibition of mouse skin tumor promotion by dietary conjugated linoleate. Nutr. Cancer. 26: 149-157.
8. Ha, Y. L., J. Storkson, and M. W. Pariza. 1990. Inhibition of bezo(a)pyrene-induced mouse forestomach neoplasia by conjugated derivatives of linoleic acid. Cancer Res. 50: 1097-1101.
9. Nicolosi, R. J., and L. Laitinen. 1996. Dietary conjugated linoleic acid reduces aortic fatty streak formation greater than linoleic acid in hypercholesterolemic hamsters. FASEB J. 10: A477.
10. Houseknecht, K. L., J. P. Vanden Heuvel, S. Y. Moya-Camarena, C. P. Portocarrero, L. W. Peck, K. P. Nickel, and M. A. Belury. 1998. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem. Biophys. Res. Commun. 244: 678-682.
11. Belury, M. A., and A. Kempa-Steczko, A. 1997. Conjugated linoleic acid modulates hepatic lipid composition in mice. Lipids. 32: 199-204.
12. Tontonoz, P., E. Hu, R. A. Graves, A. Budavari, and B. M. Spiegelman. 1994. mPPARγ2: tissue specific regulator of an adipocyte enhancer. Genes Dev. 8: 1224-1234.
13. Devchand, P. R., H. Keller, J. M. Peters, M. Vazquez, F. Gonzalez, and W. Wahli. 1996. The PPARα-leukotriene B4 pathway to inflammation control. Nature. 384: 39-43.
14. Kliewer, S. A., S. S. Sundseth, S. A. Jones, P. J. Brown, G. B. Wisely, C. S. Koble, P. Devchand, W. Wahli, T. M. Willson, J. M., Lenhard, and J. M. Lehmann. 1997. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α an γ. Proc. Natl. Acad. Sci. USA. 94: 4318-4323.
15. Forman, B. M., J. Chen, and R. M. Evans. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc. Natl. Acad. Sci. USA. 94: 4312-4317.
16. Krey, G., O. Braissant, F. L'Horset, E. Kalkhoven, M. Perroud, M. G. Parker, and W. Wahli. 1997. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by co-activator-dependent receptor ligand assay. Mol. Endocrinol. 11: 779-791.
17. Belury, M. A., S. Y. Moya-Camarena, K-L. Liu, and J. P. Vanden Heuvel. 1997. Dietary conjugated linoleic acid induces peroxisome-specific enzyme accumulation and ornithine decarboxylase activity in mouse liver. J. Nutr. Biochem. 8: 579-584.
18. Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Wilson, and S. A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ. J. Mol. Chem. 270: 12953-12956.
19. Nichols, J. S., D. J. Parks, T. G. Consler, and S. G. Blanchard. 1998. Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain. Anal. Biochem. 257: 112-119.
20. Kliewer, S. A., B. M. Forman, B. Blumberg, E. S. Ong, U. Borgmeyer, D. J. Mangelsdorf, K. Umesono, and R. M. Evans. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA. 91: 7355-7359.
21. Vanden Heuvel, J. P., G. C. Clark, M. C., Kohn, A. M. Tritscher, W. F. Greenlee, G. W. Lucier, and D. A. Bell. 1994. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res. 54: 62-68.
22. Bayly, A. C., N. J. French, C. Dive, and R. A. Roberts. 1993. Non-genotoxic hepatocarcinogens in vitro: the FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis. J. Cell Sci. 104: 307-315.
23. Poirier, H., O. Braissant, I. Noit, W. Wahli, and P. Besnard. 1997. 9-cis-Retinoic acid enhances fatty acid-induced expression of the liver-fatty acid binding protein gene. FEBS. Lett. 412: 480-484.
24. Xu, H. E., M. H. Lambert, V. G. Montana, D. J. Parks, S. G. Blanchard, P. J. Brown, D. D. Sternbach, J. M. Lehmann, G. B. Wisely, T. M. Willson, S. A. Kliewer, and M. V. Milburn. 1999. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell. In press.
25. Belury, M. A., and J. P. Vanden Heuvel. 1997. Protection against cancer and heart disease by CLA: potential mechanism of action. Nutr. Dis. Update. 1: 58-63.
26. Keller, H., C. Dreyer, J. Medin, A. Mahfoudi, K. Ozato, and W. Wahli. 1993. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA. 90: 2160-2164.
27. Lee, S. S-T., T. Pineau, J. Drago, E. J. Lee, J. Owens, D. L. Kroetz, P. M. Fernandez-Salguero, H. Westphal, and F. Gonzalez. 1995. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell Biol. 15: 3012-3022.
28. Bocos, C., M. Gottlicher, K. Gearing, G. Banner, E. Enmark, M. Teboul, A. Crickmore, and J. A. Gustafsson. 1995. Fatty acid activation of peroxisome proliferator activated receptor (PPAR). J. Steroid Biochem. Mol. Biol. 53: 467-473.
29. Gottlicher, M., E. Widmark, Q. Li, and J. A. Gustafsson. 1992. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 89: 4653-4657.
30. Issemann, I., R. A. Prince, J. D. Tugwood, and S. Green. 1993. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol. 11: 37-47.
31. Meunier-Durmort, C., H. Poirier, I. Niot, C. Forest, and P. Besnard. 1996. Up-regulation of the expression of the gene for liver fatty acid-binding protein by long chain fatty acids. Biochem. J. 319: 483-487.
32. Schoonjans, K., B. Staels, and J. Auwerx. 1996. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37: 907-925.
33. Sterchele, P. F., J. P. Vanden Heuvel, J. W. Davis II, E. Shargo, J. Knudsen, and E. Peterson. 1994. Induction of hepatic acyl-CoA binding protein and liver fatty acid binding protein by perfluorodecanoic acid in rats. Lack of correlation with hepatic long chain acyl-CoA levels. Biochem. Pharmacol. 48: 955-966.
34. Issemann, I., R. Prince, J. Tugwood, and S. Green. 1992. A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation? Biochem. Soc. Trans. 20: 823-827.
35. Dreyer, C., G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli. 1992. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68: 879-887.
36. Tugwood, J. D., I. Issemann, R. G. Anderson, K. R. Bundell, W. L. McPheat, and S. Green. 1992. The mouse peroxisome proliferator-activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11: 433-439.
37. Johnson, E. F., C. A. N. Palmer, K. J. Griffin, and M-H. Hsu. 1996. Role of peroxisome proliferator-activated receptor in cytochrome P450 A gene regulation. FASEB J. 10: 1241-1248.